Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/26674
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLucia, A-
dc.contributor.authorMartinuzzi, A-
dc.contributor.authorNogales-Gadea, G-
dc.contributor.authorQuinlivan, R-
dc.contributor.authorReason, S-
dc.contributor.authorBali, D-
dc.contributor.authorGodfrey, R-
dc.contributor.authorHaller, R-
dc.contributor.authorKishnani, P-
dc.contributor.authorLaforêt, P-
dc.contributor.authorLøkken, N-
dc.contributor.authorMusumeci, O-
dc.contributor.authorSantalla, A-
dc.contributor.authorTarnopolsky, M-
dc.contributor.authorToscano, A-
dc.contributor.authorVissing, J-
dc.contributor.authorVoermans, N-
dc.contributor.authorWakelin, A-
dc.contributor.otherInternational Association for Muscle Glycogen Storage Disease study group-
dc.date.accessioned2023-06-18T09:59:50Z-
dc.date.available2023-06-18T09:59:50Z-
dc.date.issued2021-10-28-
dc.identifierORCID iD: Andrea Martinuzzi https://orcid.org/0000-0002-0319-3579; Gisela Nogales-Gadea https://orcid.org/0000-0002-7414-212X; Stacey Reason https://orcid.org/0000-0002-6240-8365 ; Richard Godfrey https://orcid.org/0000-0003-3700-3603.-
dc.identifier.citationLucia, A. et al. on behalf of the International Association for Muscle Glycogen Storage Disease study group (2021) 'Clinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study group', Neuromuscular Disorders, 31 (12), pp. 1296 - 1310. doi: 10.1016/j.nmd.2021.10.006.en_US
dc.identifier.issn0960-8966-
dc.identifier.urihttps://bura.brunel.ac.uk/handle/2438/26674-
dc.descriptionSupplementary material is available online at https://www.sciencedirect.com/science/article/pii/S0960896621006878#sec0054 .en_US
dc.description.abstractHighlights: • Management of physical activity intolerance in GSD V and GSD VII is nuanced and impacts activities of daily living (ADL). • Guidelines support clinicians in multiple disciplines across the continuum of care and lifespan of patients. • Overview of management, including guidance on physical activity, nutrition, pain, medical emergencies, and rehabilitation. • Considerations for general medical care, including established and emerging concomitant conditions, potential drug-disease interactions, surgery, and obstetrics. • Emerging issues and knowledge gaps are highlighted.en_US
dc.description.sponsorshipReneo Pharmaceuticals Inc.; International Association for Muscle Glycogen Storage Disease.en_US
dc.format.extent1296 - 1310-
dc.format.mediumPrint-Electronic-
dc.languageEnglish-
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.rightsCopyright © 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( https://creativecommons.org/licenses/by-nc-nd/4.0/ )-
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/-
dc.subjectMcArdleen_US
dc.subjectTaruien_US
dc.subjectmyophosphorylaseen_US
dc.subjectphosphofructokinaseen_US
dc.subjectglycogenen_US
dc.subjectclinical practice guidelinesen_US
dc.titleClinical practice guidelines for glycogen storage disease V & VII (McArdle disease and Tarui disease) from an international study groupen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1016/j.nmd.2021.10.006-
dc.relation.isPartOfNeuromuscular Disorders-
pubs.issue12-
pubs.publication-statusPublished-
pubs.volume31-
dc.identifier.eissn1873-2364-
dc.rights.holderThe Author(s)-
Appears in Collections:Dept of Life Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright © 2021 The Author(s). Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license ( https://creativecommons.org/licenses/by-nc-nd/4.0/ )1.24 MBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons